Miguel A. Gay-Gonzalez

Miguel A. Gay-Gonzalez

Rheumatology Div
Santander And Univ. Of The Witwatersrand, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 698 publications

Clinical, biological, and radiological changes under therapy, and criteria for clinical response and remission in adult-onset Still's disease: a systematic literature review informing the development of the European Alliance of Associations for Rheumatology (EULAR) criteria for assessing disease activity.

Clinical, biological, and radiological changes under therapy, and criteria for clinical response and remission in adult-onset Still's disease: a systematic literature review informing the development of the European Alliance of Associations for Rheumatology (EULAR) criteria for assessing disease activity.

Journal: EULAR rheumatology open

Published: August 01, 2026

Items identified by expert physicians for the development of the criteria for the assessment of disease activity for adult-onset Still's disease: results of a web-based Delphi study informing the development of the European Alliance of Associations for Rheumatology (EULAR) criteria for the assessment of disease activity in these patients.

Items identified by expert physicians for the development of the criteria for the assessment of disease activity for adult-onset Still's disease: results of a web-based Delphi study informing the development of the European Alliance of Associations for Rheumatology (EULAR) criteria for the assessment of disease activity in these patients.

Journal: EULAR rheumatology open

Published: August 01, 2026

Evidence-based guidelines for the diagnosis and management of adult-onset IgA vasculitis.

Evidence-based guidelines for the diagnosis and management of adult-onset IgA vasculitis.

Journal: Nature reviews. Rheumatology

Published: July 28, 2026

Interleukin-2 is associated with cytopenias in systemic lupus erythematosus.

Interleukin-2 is associated with cytopenias in systemic lupus erythematosus.

Journal: Autoimmunity

Published: July 25, 2026

Emerging pharmacotherapies for large-vessel vasculitis.

Emerging pharmacotherapies for large-vessel vasculitis.

Journal: Expert opinion on pharmacotherapy

Published: June 15, 2026

N-acetylcysteine regulates the endoplasmic reticulum stress response in CEP-like chondrocytes exposed to proinflammatory cytokines.

N-acetylcysteine regulates the endoplasmic reticulum stress response in CEP-like chondrocytes exposed to proinflammatory cytokines.

Journal: Free radical biology & medicine

Published: June 02, 2026

Targeted small molecules in polymyalgia rheumatica: the emerging role of JAK inhibitors beyond glucocorticoids and DMARDs.

Targeted small molecules in polymyalgia rheumatica: the emerging role of JAK inhibitors beyond glucocorticoids and DMARDs.

Journal: Expert opinion on pharmacotherapy

Published: April 30, 2026

Ultrasensitive serum interferon alpha equals interferon signatures as a marker of lupus disease activity.

Ultrasensitive serum interferon alpha equals interferon signatures as a marker of lupus disease activity.

Journal: iScience

Published: April 15, 2026

Increased lymphoma risk in patients with systemic manifestations of Sjögren's disease: a population-based study.

Increased lymphoma risk in patients with systemic manifestations of Sjögren's disease: a population-based study.

Journal: Frontiers in medicine

Published: April 09, 2026

Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

Journal: Annals of the rheumatic diseases

Published: March 25, 2026

Rheumatoid factor and anticitrullinated protein antibody status jointly influence the association between disease activity and cardiovascular risk in rheumatoid arthritis.

Rheumatoid factor and anticitrullinated protein antibody status jointly influence the association between disease activity and cardiovascular risk in rheumatoid arthritis.

Journal: RMD open

Published: March 09, 2026

Cardiovascular-Kidney-Metabolic syndrome predicts the development of cardiovascular events in patients with rheumatoid arthritis: a 10-years prospective analysis from the CARMA cohort.

Cardiovascular-Kidney-Metabolic syndrome predicts the development of cardiovascular events in patients with rheumatoid arthritis: a 10-years prospective analysis from the CARMA cohort.

Journal: Seminars in arthritis and rheumatism

Published: February 25, 2026

Showing 1-12 of 698

Last Updated: 09/26/2026